UK Offers Fresh Funding For New Drugs & Vaccines Against AMR
Executive Summary
New funding from the UK’s antimicrobial resistance innovation fund is to be welcomed, but the UK pharmaceutical industry body, the ABPI, has cautioned that “multiple global solutions” bringing together governments, health care systems and the industry are needed if research efforts are to result in effective new antibiotics.
You may also be interested in...
EU Reforms Include ‘Prudent-Use’ Targets For Cuts To Antibiotic Consumption
The European Commission says at least 65% of all human consumption of antibiotics should be of products that come under the World Health Organization’s AWaRe (Access, Watch, Reserve) classification, which have a lower risk of resistance.
EU Plans To Trial Antimicrobial Voucher Scheme For 15 Years
Proposals for an EU voucher that would encourage the development of “game-changing” antimicrobials are accompanied by plans for procurement mechanisms to guarantee revenues for companies regardless of sales volumes. But one law firm said the conditions attached to the voucher were so strict that the scheme appeared “unworkable.”
England: Shionogi And Pfizer Ink ‘World First’ Payment Model Deal For Antibiotics
Shionogi and Pfizer have formally agreed to a scheme that offers companies a new and sustainable payment model for innovating in antibiotics.